Work

Changes in Fatigue, Functional Status, and Sarcopenia Risk in Patients With Cancer: A Prospective Cohort Study

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Purpose To analyze changes in cancer-related fatigue, sarcopenia risk, and functional status in patients undergoing chemotherapy and investigate associations among these outcomes. Methods A prospective cohort study was conducted with 104 patients undergoing chemotherapy with taxanes and/or platinum-based agents at an oncology outpatient clinic in northern Rio Grande do Sul, Brazil. Three assessments were performed at the beginning, midpoint, and end of treatment using the Revised Piper Fatigue Scale, SARC-CalF, and Thirty-Second Sit-to-Stand Test. Data were analyzed using descriptive and inferential statistics, with a significance level of 5%. Results Of the 104 patients initially assessed, 62 completed all three assessments. Fatigue increased from 2.83 ± 1.90 to 4.96 ± 1.93 points ( p < 0.001). Sarcopenia risk ( p = 0.965) and functional status ( p = 0.219) remained stable. At the first assessment, fatigue was weakly positively correlated with sarcopenia risk ( r = 0.270; p = 0.006), with no significant correlation thereafter. Fatigue was weakly negatively correlated with functional status at the first ( r = − 0.310; p = 0.001) and second assessments ( r = − 0.345; p = 0.002*), but not at the third. Conclusion Cancer-related fatigue increased during chemotherapy, whereas sarcopenia risk and functional status remained stable. The association between higher fatigue and lower functional status at the first two assessments highlights the importance of monitoring fatigue and functional status throughout cancer treatment.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7237242013
Cites: 15
Cited by:
Related to: 10